| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 655950 | 99126013 | ENBREL 25 mg SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | ENBREL 25 mg SOLUCION INYECTABLE EN JERINGAS PRECARGADAS, 4 jeringas precargadas de 1 ml | 25 mg inyectable 1 ml | 33 | 4 | 61 | 4 jeringas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99126013/99126013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99126013/99126013_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2006-10-04 | 1 | 1 | 1 | 2006-10-04 | 2006-10-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 655953 | 99126017 | ENBREL 50 mg SOLUCION INYECTABLE EN JERINGAS PRECARGADAS | ENBREL 50 mg SOLUCION INYECTABLE EN JERINGAS PRECARGADAS, 4 jeringas precargadas de 1 ml | 50 mg | 33 | 4 | 61 | 4 jeringas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99126017/99126017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99126017/99126017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2006-10-04 | 1 | 1 | 1 | 2006-10-04 | 2006-10-04 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 656756 | 61025 | DIFTAVAX SUSPENSION INYECTABLE EN JERINGA PRECARGADA | DIFTAVAX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61025/61025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61025/61025_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 1996-05-01 | 1 | 1 | 1 | 1996-05-01 | 2008-04-30 | 1 | 2012-01-02 | 885657, 832113 | View Edit Delete | |||||||||||
| 654701 | 67939 | IBUPROFENO (ARGININA) CINFA 600 mg GRANULADO PARA SOLUCION ORAL EFG | IBUPROFENO (ARGININA) CINFA 600 mg GRANULADO PARA SOLUCION ORAL EFG , 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67939/67939_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67939/67939_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-07-07 | 1 | 1 | 1 | 2006-07-07 | 2006-07-07 | 1 | 2015-01-14 | View Edit Delete | ||||||||||||
| 654702 | 67939 | IBUPROFENO (ARGININA) CINFA 600 mg GRANULADO PARA SOLUCION ORAL EFG | IBUPROFENO (ARGININA) CINFA 600 mg GRANULADO PARA SOLUCION ORAL EFG , 40 sobres | 600 mg | 35 | 40 | 64 | 40 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67939/67939_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67939/67939_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-07-07 | 1 | 1 | 1 | 2006-07-07 | 2006-07-07 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656188 | 68088 | PLANTAGO OVATA CINFA 3,5 g POLVO PARA SUSPENSION ORAL | PLANTAGO OVATA CINFA 3,5 g POLVO PARA SUSPENSION ORAL, 30 sobres | 3.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68088/68088_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68088/68088_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-18 | 1 | 1 | 1 | 2006-10-18 | 2006-10-18 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656237 | 68105 | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG, 20 sobres | 1.500 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68105/68105_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68105/68105_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-25 | 1 | 1 | 1 | 2006-10-25 | 2006-10-25 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656238 | 68105 | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG | GLUCOSAMINA CINFA 1500 mg POLVO PARA SOLUCION ORAL EFG, 30 sobres | 1.500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68105/68105_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68105/68105_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-25 | 1 | 1 | 1 | 2006-10-25 | 2006-10-25 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656748 | 29243 | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. , 60 sobres | 2.500 mg (1.000 mg Ca) | 35 | 60 | 64 | 60 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/29243/29243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/29243/29243_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1958-05-01 | 1 | 1 | 1 | 1958-05-01 | 2008-03-06 | 1 | 2011-09-09 | 652446, 820357 | View Edit Delete | |||||||||||
| 656427 | 68200 | IBUFARMALID 400 mg SUSPENSION ORAL | IBUFARMALID 400 mg SUSPENSION ORAL, 30 sobres | 400 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68200/68200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68200/68200_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6345 | FARMALIDER S.A. | 2006-11-27 | 1 | 1 | 1 | 2006-11-27 | 2006-11-27 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 656254 | 65455 | XUMADOL 1 g GRANULADO EFERVESCENTE EFG | XUMADOL 1 g GRANULADO EFERVESCENTE EFG , 20 sobres | 1.000 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65455/65455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65455/65455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 2003-06-23 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2012-10-09 | 850891 | View Edit Delete | |||||||||||
| 656255 | 65455 | XUMADOL 1 g GRANULADO EFERVESCENTE EFG | XUMADOL 1 g GRANULADO EFERVESCENTE EFG , 40 sobres | 1.000 mg | 35 | 40 | 64 | 40 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65455/65455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65455/65455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 2003-06-23 | 1 | 1 | 1 | 2015-05-11 | 2015-05-11 | 1 | 2012-10-09 | 819458 | View Edit Delete | |||||||||||
| 654666 | 67916 | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG , 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67916/67916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67916/67916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-07-04 | 1 | 1 | 1 | 2006-07-04 | 2006-07-04 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 654668 | 67918 | IBUPROFENO KERN PHARMA 600 mg GRANULADO EFERVESCENTE EFG | IBUPROFENO KERN PHARMA 600 mg GRANULADO EFERVESCENTE EFG, 40 sobres | 600 mg | 35 | 40 | 64 | 40 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67918/67918_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67918/67918_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-07-04 | 1 | 1 | 1 | 2006-07-04 | 2006-07-04 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 654685 | 67930 | IBUKERN 600 MG SUSPENSION ORAL | IBUKERN 600 MG SUSPENSION ORAL , 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67930/67930_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67930/67930_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-07-10 | 1 | 1 | 1 | 2006-07-10 | 2006-07-10 | 1 | 2015-04-29 | View Edit Delete | ||||||||||||
| 656185 | 68086 | IBUDOL PEDIÁTRICO 200 MG SUSPENSIÓN ORAL | IBUDOL PEDIÁTRICO 200 MG SUSPENSIÓN ORAL , 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68086/68086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68086/68086_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-10-19 | 1 | 1 | 1 | 2006-10-19 | 2006-10-19 | 1 | 2015-09-15 | View Edit Delete | ||||||||||||
| 656412 | 68194 | IBUDOL 400 MG SUSPENSION ORAL | IBUDOL 400 MG SUSPENSION ORAL , 20 sobres | 400 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68194/68194_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68194/68194_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-11-22 | 1 | 1 | 1 | 2006-11-22 | 2006-11-22 | 1 | 2015-06-12 | View Edit Delete | ||||||||||||
| 658197 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 7 parches | 14 mg/24 h | 35 | 7 | 28 | 7 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658198 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 14 parches | 14 mg/24 h | 35 | 14 | 28 | 14 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete | ||||||||||||
| 658200 | 68301 | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO | NICOTINELL 14 MG/24 HORAS PARCHE TRANSDERMICO , 28 parches | 14 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68301/68301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68301/68301_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71300 | VEMEDIA PHARMA HISPANIA S.A. | 2006-12-22 | 1 | 1 | 1 | 2006-12-22 | 2006-12-22 | 0 | 2011-10-28 | View Edit Delete |
Page 130 of 1036, showing 20 records out of 20709 total, starting on record 2581, ending on 2600